Clinical trial
BOTOX® in the Treatment of Crow's Feet Lines in Japan
NCT01797081 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BOTOX® in the Treatment of Crow's Feet Lines in Japan
- Lead sponsor
- Allergan
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- July 7, 2014
- Enrollment
- 300 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
crow's feet lines, lateral canthus rhytides